Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Jong-Mu Sun · SciRah

Researcher profile · Semantic Scholar

Jong-Mu Sun

Share profile

Jong-Mu Sun — researcher profile on SciRah

h-index: 57
Works: 414
Citations: 15K

Most-cited papers

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study.
Jong-Mu Sun, Lin Shen, M. Shah, P. Enzinger +21 more
2021The Lancet1,284 citations Open access
Semantic Scholar
Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study
Lin Shen, Ken Kato, Sung-Bae Kim, J. Ajani +26 more
2022Journal of Clinical Oncology223 citations Open access
Semantic Scholar
Artificial Intelligence–Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non–Small-Cell Lung Cancer
Sehhoon Park, C. Ock, Hyojin Kim, Sérgio Pereira +25 more
2022Journal of Clinical Oncology184 citations Open access
Semantic Scholar
Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non–Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)
Sehhoon Park, Tae Min Kim, Ji-Youn Han, Gyeong-Won Lee +20 more
2023Journal of Clinical Oncology166 citations Open access
Semantic Scholar
Longitudinal Monitoring of Circulating Tumor DNA From Plasma in Patients With Curative Resected Stage I-IIIA EGFR Mutant-Non-Small Cell Lung Cancer.
H. Jung, B. Ku, Yeon Jeong Kim, Sehhoon Park +14 more
2023Journal of Thoracic Oncology75 citations
Semantic Scholar
A Phase 1/2 Study of Lazertinib 240 mg in Patients with Advanced EGFR T790M-Positive Non-Small Cell Lung Cancer After Prior EGFR Tyrosine Kinase Inhibitors.
B. Cho, Ji-Youn Han, Sang-We Kim, K. Lee +22 more
2021Journal of Thoracic Oncology71 citations Open access
Semantic Scholar
Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
Sehhoon Park, D. Oh, Yoon-La Choi, S. Chi +3 more
2022Cancer66 citations
Semantic Scholar
High concordance of actionable genomic alterations identified between circulating tumor DNA–based and tissue‐based next‐generation sequencing testing in advanced non–small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program
Sehhoon Park, S. Olsen, B. Ku, Min-Sang Lee +7 more
2021Cancer66 citations Open access
Semantic Scholar
Clonal expansion of resident memory T cells in peripheral blood of patients with non-small cell lung cancer during immune checkpoint inhibitor treatment
Hyunsu Kim, Sehhoon Park, K. Han, Naeun Lee +7 more
2023Journal for ImmunoTherapy of Cancer51 citations Open access
Semantic Scholar
Outstanding clinical efficacy of PD-1/PD-L1 inhibitors for pulmonary pleomorphic carcinoma.
Ji-Yun Lee, Yoon La Choi, H. Jung, Se-Hoon Lee +4 more
2020European Journal of Cancer50 citations
Semantic Scholar
Durvalumab with chemoradiotherapy for limited-stage small-cell lung cancer.
Sehhoon Park, J. Noh, Yoon-La Choi, S. Chi +6 more
2022European Journal of Cancer48 citations
Semantic Scholar
Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancer
Sehhoon Park, Tae Hee Hong, Soohyun Hwang, S. Heeke +16 more
2024EBioMedicine45 citations Open access
Semantic Scholar
Trends in Survival Rates of Non–Small Cell Lung Cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020
S. Chi, H. Yu, Yoon-La Choi, Sehhoon Park +8 more
2023JAMA Network Open36 citations Open access
Semantic Scholar
Therapeutic efficacy of Cancer vaccine Adjuvanted with Nanoemulsion loaded with TLR7/8 agonist in lung Cancer model.
J. Koh, Sohyun Kim, Sang Nam Lee, Sun-Young Kim +14 more
2021Nanomedicine: Nanotechnology, Biology and Medicine35 citations
Semantic Scholar
Longitudinal monitoring by next‐generation sequencing of plasma cell‐free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors
M. Kwon, B. Ku, S. Olsen, Sehhoon Park +8 more
2022Cancer Medicine33 citations Open access
Semantic Scholar
Bevacizumab plus atezolizumab following progression on atezolizumab monotherapy in pretreated non-small cell lung cancer patients: An open-label, two-stage, phase II trial.
Ji-Yun Lee, J. Koh, H. Kim, Su-Jung Hong +8 more
2022Journal of Thoracic Oncology30 citations Open access
Semantic Scholar
Feasibility of an Interactive Health Coaching Mobile App to Prevent Malnutrition and Muscle Loss in Esophageal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy: Prospective Pilot Study
Kyungmi Yang, D. Oh, J. Noh, H. Yoon +7 more
2021Journal of Medical Internet Research29 citations Open access
Semantic Scholar
The different central nervous system efficacy among gefitinib, erlotinib and afatinib in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer
H. Jung, Sook-young Woo, Se-Hoon Lee, J. Ahn +3 more
2020Translational Lung Cancer Research29 citations Open access
Semantic Scholar
Intracellular Adhesion Molecule‐1 Improves Responsiveness to Immune Checkpoint Inhibitor by Activating CD8+ T Cells
Se-Hoon Lee, Yeongmin Kim, Bu-Nam Jeon, Gihyeon Kim +20 more
2023Advancement of science27 citations Open access
Semantic Scholar
A phase II study of palbociclib for recurrent or refractory advanced thymic epithelial tumors (KCSG LU17-21).
H. Jung, Miso Kim, H. Kim, Joo-Hang Kim +11 more
2022Journal of Thoracic Oncology25 citations
Semantic Scholar
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non‐small cell lung cancer
B. Ku, Youjin Kim, Kyoung Young Lee, Sang-Yeob Kim +5 more
2021European Journal of Immunology24 citations Open access
Semantic Scholar
Transcriptional upregulation of CXCL13 is correlated with a favorable response to immune checkpoint inhibitors in lung adenocarcinoma
Sehhoon Park, H. Cha, H. Kim, B. Lee +9 more
2022Cancer Medicine23 citations Open access
Semantic Scholar
First-line pembrolizumab plus chemotherapy versus chemotherapy in advanced esophageal cancer: Longer-term efficacy, safety, and quality-of-life results from the phase 3 KEYNOTE-590 study.
J. Metges, Ken Kato, Jong-Mu Sun, M. Shah +16 more
2022Journal of Clinical Oncology21 citations Open access
Semantic Scholar
Biomarker‐driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancer
Sehhoon Park, Yu-Jung Kim, Young Joo Min, P. Mortimer +10 more
2023Cancer20 citations
Semantic Scholar
Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancer
H. Yoon, D. Oh, J. Noh, W. Cho +5 more
2021Journal of Cachexia, Sarcopenia and Muscle20 citations Open access
Semantic Scholar
Characteristics and Clinical Outcomes of Non-small Cell Lung Cancer Patients in Korea With MET Exon 14 Skipping
J. Hur, B. Ku, J. Shim, H. Jung +5 more
2020In Vivo20 citations Open access
Semantic Scholar
Dynamics of circulating immune cells during chemoradiotherapy in patients with non-small cell lung cancer support earlier administration of anti-PD-1/PD-L1 therapy.
K. H. Kim, H. Pyo, Hoyoung Oh, J. Noh +13 more
2022International Journal of Radiation Oncology, Biology, Physics19 citations Open access
Semantic Scholar
Association of T cell senescence with radiation pneumonitis in patients with non-small cell lung cancer.
K. H. Kim, H. Pyo, Hoyoung Lee, D. Oh +14 more
2022International Journal of Radiation Oncology, Biology, Physics19 citations Open access
Semantic Scholar
Continuation of Pembrolizumab with Additional Chemotherapy after Progression with PD-1/PD-L1 Inhibitor Monotherapy in Patients with Advanced NSCLC: A Randomized, Placebo-Controlled Phase II Study
H. Jung, Sehhoon Park, Yoon-La Choi, Se-Hoon Lee +3 more
2022Clinical Cancer Research18 citations Open access
Semantic Scholar
Molecular subtypes of small cell lung cancer transformed from adenocarcinoma after EGFR tyrosine kinase inhibitor treatment
Soohyun Hwang, Tae Hee Hong, Sehhoon Park, H. Jung +6 more
2021Translational Lung Cancer Research18 citations Open access
Semantic Scholar
Lazertinib for patients with NSCLC harboring uncommon EGFR mutations: A phase II multi-center trial.
Sehhoon Park, H. Ahn, S. Lee, Y.J. Min +11 more
2025Journal of Thoracic Oncology14 citations Open access
Semantic Scholar
First-Line Alectinib vs. Brigatinib in Advanced Non–Small Cell Lung Cancer with ALK Rearrangement: Real-World Data
Youngkyun Jeon, Sehhoon Park, H. Jung, Jong-Mu Sun +3 more
2023Cancer research and treatment : official journal of Korean Cancer Association14 citations Open access
Semantic Scholar
Clinical, pathological, and molecular prognostic factors in patients with early-stage EGFR mutant NSCLC.
H. Jung, Jinyeong Lim, Yoon-La Choi, Se-Hoon Lee +17 more
2022Clinical Cancer Research13 citations Open access
Semantic Scholar
Extrapulmonary tuberculosis in patients with RET fusion-positive non-small cell lung cancer treated with pralsetinib: A Korean single-centre compassionate use experience.
Yong-Pyo Lee, Byeong-Ho Jeong, Yeonghee Eun, C. Kang +7 more
2021European Journal of Cancer13 citations
Semantic Scholar
The clinical efficacy of olaparib monotherapy or combination with ceralasertib (AZD6738) in relapsed small cell lung cancer.
Sehhoon Park, P. Mortimer, Simon A. Smith, H. Kim +7 more
202113 citations
Semantic Scholar
Prognostic impact of muscle mass loss in elderly patients with oesophageal cancer receiving neoadjuvant chemoradiation therapy
Jeong Yun Jang, D. Oh, J. Noh, Jong-Mu Sun +2 more
2024Journal of Cachexia, Sarcopenia and Muscle12 citations Open access
Semantic Scholar
Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune‐related hepatitis in non–small cell lung cancer patients with chronic hepatitis B
J. Hong, Ji-Yun Lee, Sehhoon Park, H. Jung +5 more
2024Cancer11 citations Open access
Semantic Scholar
Role of Circulating Tumor DNA Profiling in Patients with Non-Small Cell Lung Cancer Treated with EGFR Inhibitor
B. Ku, Yeon Jeong Kim, Donghyun Park, Se-Hoon Lee +4 more
2022Oncology11 citations
Semantic Scholar
Cellular plasticity and immune microenvironment of malignant pleural effusion are associated with EGFR-TKI resistance in non–small-cell lung carcinoma
H. Jeong, Hayoon Lee, Hyemin Kim, Jin-Ho Jang +14 more
2022iScience11 citations Open access
Semantic Scholar
Predicting disease recurrence in limited disease small cell lung cancer using cell-free DNA-based mutation and fragmentome analyses
Sehhoon Park, Jun-Kyu Kang, Naeun Lee, Se-Hoon Lee +9 more
2024Translational Lung Cancer Research9 citations Open access
Semantic Scholar
Pulmonary function and toxicities of proton versus photon for limited-stage small cell lung cancer
S. Seo, H. Pyo, Y. Ahn, D. Oh +9 more
2023Radiation Oncology Journal9 citations Open access
Semantic Scholar
EGFR Mutation–Positive Unresectable Stage III Non-Squamous Lung Cancer Is Associated with a High Incidence of Brain Metastasis
Hongsik Kim, Sehhoon Park, H. Jung, Jong-Mu Sun +3 more
2022Cancer research and treatment : official journal of Korean Cancer Association9 citations Open access
Semantic Scholar
Prospective investigation of biomarker and resistance mechanism using longitudinal cell-free NGS in non-small cell lung cancer with EGFR exon 20 insertion treated with amivantamab.
Geun-Ho Park, Sehhoon Park, Hyemin Kim, H. Jung +4 more
2025European Journal of Cancer8 citations Open access
Semantic Scholar
Real-World Outcomes of Immunotherapy in Second- or Later-Line Non-Small Cell Lung Cancer with Actionable Genetic Alterations
Soojin Jun, Sehhoon Park, Jong-Mu Sun, Se-Hoon Lee +4 more
2023Cancers8 citations Open access
Semantic Scholar
ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer
B. Ku, J. Heo, Jinchul Kim, Jong-Mu Sun +4 more
2021Investigational new drugs8 citations Open access
Semantic Scholar
Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer
Nayoung Kim, Sehhoon Park, Areum Jo, Hye Hyeon Eum +17 more
2024bioRxiv7 citations
Semantic Scholar
Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancer
Hye In Kim, Won Gu Kim, Mijin Kim, N. Ko +16 more
2024Cancer Immunology and Immunotherapy7 citations Open access
Semantic Scholar
Neoadjuvant Nivolumab Therapy for Esophageal Squamous Cell Carcinoma: A Single-Arm, Phase II Study
Sehhoon Park, Yurimi Lee, Ji-Yun Lee, Y. Min +7 more
2023Cancer research and treatment : official journal of Korean Cancer Association7 citations Open access
Semantic Scholar
Effectiveness and safety of amivantamab in EGFR exon 20 insertion (E20I) mutations in non-small cell lung cancer (NSCLC)
D. Choi, H. Jung, Sehhoon Park, Jong-Mu Sun +3 more
2023Translational Lung Cancer Research7 citations Open access
Semantic Scholar
Health-related quality of life (HRQoL) of pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase III KEYNOTE-590 study.
W. Mansoor, A. Kulkarni, Ken Kato, Jong-Mu Sun +16 more
20217 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

H. Jung×37
Invite
H. Jung — researcher profile on SciRah
J. Ahn×35
Invite
J. Ahn — researcher profile on SciRah
Sehhoon Park×34
Invite
Sehhoon Park — researcher profile on SciRah
M. Ahn×30
Invite
M. Ahn — researcher profile on SciRah

×24

Invite

Keunchil Park — researcher profile on SciRah

Se-Hoon Lee×23

Invite

Se-Hoon Lee — researcher profile on SciRah

Invite

B. Ku — researcher profile on SciRah

Myung-Ju Ahn×11

Invite

Myung-Ju Ahn — researcher profile on SciRah

Invite

Se-Hoon Lee — researcher profile on SciRah

Invite

J. Noh — researcher profile on SciRah

Invite

H. Kim — researcher profile on SciRah

Yoon-La Choi×6

Invite

Yoon-La Choi — researcher profile on SciRah